Valacyclovir in Immunocompromised Children
Part of paid clinical trials in Philadelphia, Pennsylvania.
- Sponsor
- Baylor College of Medicine
- Study ID
- NCT00059592
- Phase
- PHASE1
- Status
- Completed
Conditions
- Bone Marrow Transplantation
- Shingles
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- Valacyclovir — DRUG
Study Details
Shingles is an infection commonly seen in children with a weakened immune system (immunocompromised children). The immune system can be weakened as a result of medications that patients receive for cancer or other serious illness or as a result of a bone marrow transplantation. Shingles in children with a weakened immune system may spread throughout the body and in some instances may be life-threatening. Acyclovir is a medication that is routinely used to treat immunocompromised children with shingles in order to prevent further spread of their shingles and to help them heal faster. Acyclovir is also given to bone marrow transplant patients to prevent reactivation of HSV infection. Valacyclovir is a new drug that is metabolized (broken down in the body) to acyclovir. Valacyclovir is given by mouth and studies done in adults have shown it to be more effective than acyclovir given by mouth. The purpose of this study is to * study the pharmacology of this drug (how the body handles this drug), * determine if oral Valacyclovir can be safely given to children with shingles, and * determine the type of side effects that occur when oral Valacyclovir is given to immunocompromised children.
Key Dates
- Start date
- Apr 7, 1998
- Status verified
- Mar 2020
- Primary completion
- Dec 30, 2004
- Completion
- May 5, 2005
Study Design
- Enrollment
- 37 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Valacycloviroral Valacyclovir three times a day for 5 to 10 days.
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| Texas Children's Hospital | Houston | Texas | 77030 | - |
Find similar trials in Philadelphia, PA
Related Studies
- Biomarkers in Transplant Recipients to Improve OutcomesRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant RecipientsPHASE2 · Recruiting · Loyola University · Maywood, Illinois